Research progress in the treatment of moyamoya disease.

分享到

Link by DOI

作者单位: ¹ 山东第一医科大学附属省立医院神经内科, 山东济南25001 ² 山东第一医科大学 (山东省医学科学院) 研究生部, 山东济南25011 ³ 首都医科大学宣武医院济南医院, 山东济南25010

关键词: cerebral revascularization drug therapy moyamoya disease platelet aggrega‐ tion inhibitors surgical procedures 外科手术烟雾病脑血管重建术药物治疗血小板聚集抑制剂

摘要: Moyamoya disease is a chronic occlusive cerebrovascular disease characterized by progressive stenosis or occlusion of the intracranial segment of the bilateral internal carotid artery and its proximal branches and abnormal collateral vessel formation. The etiology of the disease is not clear, which may be related to genetic, vascular inflammation, immune injury and other factors. The treatment mainly includes surgical treatment and drug treatment. Surgical treatment includes direct vascular reco...更多; Moyamoya disease is a chronic occlusive cerebrovascular disease characterized by progressive stenosis or occlusion of the intracranial segment of the bilateral internal carotid artery and its proximal branches and abnormal collateral vessel formation. The etiology of the disease is not clear, which may be related to genetic, vascular inflammation, immune injury and other factors. The treatment mainly includes surgical treatment and drug treatment. Surgical treatment includes direct vascular reconstruction, indirect vascular reconstruction and combined vascular reconstruction. Drug treatment mainly includes antiplatelet drugs, anticoagulant drugs, statins, calcium channel blockers, brain cell protection and circulation improvement drugs. At present, there is no effective means to reverse or prevent the progression of moyamoya disease, and the benefits of surgery and drug treatment are not exact.收起

列表公用js 卡片页统计

相同作者单位文献